Invention Grant
- Patent Title: Pyrazolopyrimidines and related heterocycles as CK2 inhibitors
-
Application No.: US14026591Application Date: 2013-09-13
-
Publication No.: US09303033B2Publication Date: 2016-04-05
- Inventor: Mustapha Haddach , Joe A. Tran , Fabrice Pierre , Collin F. Regan , Nicholas Raffaele , Suchitra Ravula , David M. Ryckman
- Applicant: SENHWA BIOSCIENCES, INC.
- Applicant Address: TW New Taipei
- Assignee: SENHWA BIOSCIENCES, INC.
- Current Assignee: SENHWA BIOSCIENCES, INC.
- Current Assignee Address: TW New Taipei
- Agency: Cooley LLP
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; C07D487/04 ; A61K31/519 ; A61K31/53 ; A61K31/5377 ; A61K31/551 ; A61K31/553 ; A61K45/06
Abstract:
The invention provides compounds that inhibit protein kinase CK2 activity (CK2 activity), and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and have the following general formula:
Public/Granted literature
- US20140094448A1 PYRAZOLOPYRIMIDINES AND RELATED HETEROCYCLES AS CK2 INHIBITORS Public/Granted day:2014-04-03
Information query
IPC分类:
